Prognostic markers for CLL - how do they help determine who gets which treatment?
Bone marrow transplant consent: insight into patient motivations
Panel discussion on novel therapies and targets for lymphoma
John Gribben et al.
Examining changes over time in CLL cell surface markers to identify cells at different stages
CLL update from ICML17: Current treatment and future directions for patients